StonvexLoading…
StonvexStonvexStonvexCore line items from DVA's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2020 2020-12-31 | Annual 2019 2019-12-31 | Q3 2019 2019-09-30 | Q2 2019 2019-06-30 |
|---|---|---|---|---|
Revenue | $11.04B | $10.92B | $8.15B | $5.37B |
Operating Income | $1.69B | $1.64B | $378.34M | $461.89M |
Net Income | $773.64M | $810.98M | $143.27M | $273.55M |
EPS (Diluted) | $6.31 | $5.27 | $0.95 | $1.64 |
Total Assets | $16.99B | $17.31B | $17.45B | $19.93B |
Total Liabilities | $14.09B | $13.81B | $13.64B | $14.50B |
Cash & Equivalents | $324.96M | $1.10B | $1.25B | $3.58B |
Free Cash Flow OCF − CapEx | $1.30B | $1.31B | $844.64M | $377.20M |
Shares Outstanding | 109.93M | 125.84M | 133.89M | 164.47M |